Eye Omega Benefits for Kids Disease Interactions
There are 2 disease interactions with Eye Omega Benefits for Kids (omega-3 polyunsaturated fatty acids).
Omega-3 fatty acids (applies to Eye Omega Benefits for Kids) arrhythmias
Moderate Potential Hazard, Moderate plausibility.
Cases of recurrent atrial fibrillation (AF) or flutter have been reported with the use of omega-3 fatty acids in patients with a symptomatic paroxysmal AF or persistent AF. This condition is more apparent within the first 2 to 3 months after the initiation of therapy. Therapy with these agents should be administered cautiously in patients with cardiac conduction disorders.
References
- (2005) "Product Information. Omacor (omega-3 polyunsaturated fatty acids)." Abbott Pharmaceutical
Omega-3 fatty acids (applies to Eye Omega Benefits for Kids) liver disease
Moderate Potential Hazard, Moderate plausibility.
Increases in alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) levels have been observed in patients receiving omega-3 fatty acids. Therapy with omega-3 fatty acid preparations should be administered cautiously in patients with hepatic impairment. Serum liver enzyme levels should be monitored periodically.
References
- (2005) "Product Information. Omacor (omega-3 polyunsaturated fatty acids)." Abbott Pharmaceutical
- (2021) "Product Information. Lovaza (omega-3 polyunsaturated fatty acids)." Woodward Pharma Services, Rev. 02-2021-00
Eye Omega Benefits for Kids drug interactions
There are 72 drug interactions with Eye Omega Benefits for Kids (omega-3 polyunsaturated fatty acids).
More about Eye Omega Benefits for Kids (omega-3 polyunsaturated fatty acids)
- Eye Omega Benefits for Kids consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: nutraceutical products
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.